Guest Writer

Lexington Partners on the essential role of secondaries

The private equity industry has outgrown its ability to self-monetize, making secondary investors a key component of the ecosystem, says Cullen Schannep, a partner at Lexington Partners.

Jefferies on CV use cases proliferating

The secondaries market continues to innovate, as the flexible structure of CVs lends itself to creative use cases and the capital flowing into these deals evolves, say Jefferies’ Ben Carper, Jason Morris and Joe Slevin.

Your value creation plan is not the problem – your operating model is

The firms that perform are not the ones with the most compelling theses. They are the ones with the most disciplined execution.

How family offices are reshaping venture investing

Family offices are becoming catalytic capital providers via direct investments, co-investments and thematic platforms, writes Steven Thayer of Ice Miller.

How GPs can use carried interest derivatives for estate planning

CPA Anthony Venette explains how gifting carried interest derivatives is a dynamic way to maintain legacy and create significant tax savings for a VC general partner’s estate.

Healthcare M&A in 2026: Five rules smart sponsors are following

Dealmaking is on the upswing, but sponsors need to rethink their methods to get to the finish line, writes Matthew Brohm of Arnall Golden Gregory.

Why pharmacy remains a compelling mid-market play

Stability continues to present pharmacy as a compelling, high-resilience investment opportunity, write Mike Hess and Dawn Perez-Slavinski of Bass, Berry & Sims.

Private wealth changes the game and breaks operating models

Many firms are scaling their private wealth efforts without a clear understanding of where capital is truly coming from, writes Liz Gaffney of InvestorFlow.

Gen II: Amid growing complexity and competition, fund administration experience is a key differentiator

Jeff Gendel, principal at Gen II Fund Services, digs into the challenges facing the fundraising market.

An inside look at a VC firm’s AI patent journey

John McBride of Norton Rose Fulbright explains how he helped venture firm Decasonic seek patent protection for an agentic AI platform.